{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:21:10Z","timestamp":1786623670672,"version":"build-2736575974"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["12323131"],"award-info":[{"award-number":["12323131"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,1]]},"DOI":"10.1093\/toxsci\/kfx219","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T23:14:56Z","timestamp":1508886896000},"page":"412-420","source":"Crossref","is-referenced-by-count":43,"title":["Editor\u2019s Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone\/Pioglitazone and Tolcapone\/Entacapone to Cause IDILI"],"prefix":"10.1093","volume":"161","author":[{"given":"Alastair","family":"Mak","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Toronto, Toronto, Ontario M5S 3M2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Kato","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Pharmacotherapy and Toxicology, Osaka University of Pharmaceutical Sciences, Osaka 569-1094, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Weston","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Toronto, Toronto, Ontario M5S 3M2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Hayes","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Guelph, Guelph, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Uetrecht","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Toronto, Toronto, Ontario M5S 3M2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"key":"key\n\t\t\t\t20180228015157_kfx219-B1","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1074\/jbc.M505266200","article-title":"A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells","volume":"281","author":"Akasaki","year":"2006","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-immunol-032414-112116","article-title":"Endoplasmic reticulum stress in immunity","volume":"33","author":"Bettigole","year":"2015","journal-title":"Annu. Rev. Immunol"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2165\/00002018-200326110-00001","article-title":"Tolcapone-related liver dysfunction: Implications for use in Parkinson\u2019s disease therapy","volume":"26","author":"Borges","year":"2003","journal-title":"Drug Saf"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B4","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/hep.27764","article-title":"Drug-induced allergic hepatitis develops in mice when myeloid-derived suppressor cells are depleted prior to halothane treatment","volume":"62","author":"Chakraborty","year":"2015","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B5","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1124\/jpet.102.042846","article-title":"Pharmacokinetics and pharmacodynamics of entacapone and tolcapone after acute and repeated administration: A comparative study in the rat","volume":"304","author":"Forsberg","year":"2003","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: Mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B7","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00702-002-0748-x","article-title":"Different toxicological profile of two COMT inhibitors in vivo: The role of uncoupling effects","volume":"109","author":"Haasio","year":"2002","journal-title":"J. Neural. Transm"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B8","first-page":"98","article-title":"Establishment and characterization of a human hepatocellular carcinoma cell line JHH-4","volume":"1","author":"Hasumura","year":"1988","journal-title":"Hum. Cell"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver\u2014from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B10","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acs.chemrestox.7b00065","article-title":"Supernatant from hepatocyte cultures with drugs that cause idiosyncratic liver injury activates macrophage inflammasomes","volume":"30","author":"Kato","year":"2017","journal-title":"Chem. Res. Toxicol"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B11","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1021\/tx500184c","article-title":"Clozapine promotes the proliferation of granulocyte progenitors in the bone marrow leading to increased granulopoiesis and neutrophilia in rats","volume":"27","author":"Lobach","year":"2014","journal-title":"Chem. Res. Toxicol"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.103.054288","article-title":"Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats","volume":"307","author":"Luyendyk","year":"2003","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B13","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1021\/acs.chemrestox.5b00305","article-title":"The combination of anti-CTLA-4 and PD1\u2013\/\u2013 mice unmasks the potential of isoniazid and nevirapine to cause liver injury","volume":"28","author":"Mak","year":"2015","journal-title":"Chem. Res. Toxicol"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B14","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1021\/acs.chemrestox.5b00137","article-title":"The role of CD8 T Cells in amodiaquine-induced liver injury in PD1\u2013\/\u2013 mice cotreated with anti-CTLA-4","volume":"28","author":"Mak","year":"2015","journal-title":"Chem. Res. Toxicol"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu. Rev. Immunol"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B16","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.27549","article-title":"Treatment of PD-1\u2212\/\u2212 mice with amodiaquine and anti-CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients","volume":"61","author":"Metushi","year":"2015","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","article-title":"Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development","volume":"118","author":"Morgan","year":"2010","journal-title":"Toxicol. Sci"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/B978-0-12-398339-8.00003-3","article-title":"Animal Models of Idiosyncratic Drug Reactions","volume":"63","author":"Ng","year":"2012","journal-title":"Adv. Pharmacol"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.toxlet.2015.10.029","article-title":"A novel cell-based assay for the evaluation of immune- and inflammatory-related gene expression as biomarkers for the risk assessment of drug-induced liver injury","volume":"241","author":"Oda","year":"2016","journal-title":"Toxicol. Lett"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-0034-1375962","article-title":"Drug-induced liver injury and drug development: Industry perspective","volume":"34","author":"Regev","year":"2014","journal-title":"Semin. Liver Dis"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40264-014-0182-7","article-title":"Evolution of the food and drug administration approach to liver safety assessment for new drugs: Current status and challenges","volume":"37","author":"Senior","year":"2014","journal-title":"Drug Saf"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","article-title":"Inflammasome activation and function in liver disease","volume":"12","author":"Szabo","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.pharmtox.47.120505.105150","article-title":"Idiosyncratic drug reactions: Current understanding","volume":"47","author":"Uetrecht","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"key\n\t\t\t\t20180228015157_kfx219-B24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1021\/tx5001333","article-title":"Activation of inflammasomes by agents causing idiosyncratic skin reactions: A possible biomarker","volume":"27","author":"Weston","year":"2014","journal-title":"Chem. Res. Toxicol"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/161\/2\/412\/24195294\/kfx219.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T01:53:13Z","timestamp":1519782793000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/161\/2\/412\/4565800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,10,24]]},"published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfx219","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732058600.793545610","asserted-by":"object"}]},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,2]]},"published":{"date-parts":[[2017,10,24]]}}}